Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 428,430 | 541,932 | 851,929 | 871,668 | 966,777 |
| Marketable Securities | 1,247,820 | 1,191,610 | 1,008,786 | 1,010,429 | 1,022,597 |
| Receivables | 400,327 | 318,855 | 236,808 | 223,836 | 214,628 |
| Inventories | 322,859 | 244,011 | 226,876 | 202,675 | 203,968 |
| Other current assets | 179,895 | 154,441 | 148,215 | 179,769 | 149,891 |
| TOTAL | $2,579,331 | $2,450,849 | $2,472,614 | $2,488,377 | $2,557,861 |
| Non-Current Assets | |||||
| PPE Net | 227,154 | 212,367 | 188,874 | 182,862 | 180,037 |
| Other Non-Current Assets | 458,091 | 446,491 | 464,402 | 388,547 | 390,468 |
| TOTAL | $685,245 | $658,858 | $653,276 | $571,409 | $570,505 |
| Total Assets | $3,264,576 | $3,109,707 | $3,125,890 | $3,059,786 | $3,128,366 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 105,483 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 164,918 | 87,948 | 109,796 | 106,710 | 95,875 |
| Accrued Expenses | 314,997 | 322,350 | 326,877 | 345,554 | 418,996 |
| Other current liabilities | N/A | 17,951 | 16,992 | 17,381 | N/A |
| TOTAL | $653,659 | $450,743 | $498,654 | $536,884 | $619,604 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,132,515 | 1,236,755 | 1,235,517 | 1,234,284 | 1,544,292 |
| Deferred Revenues | 50,416 | 22,494 | 44,989 | 67,239 | 89,244 |
| Other Non-Current Liabilities | 182,065 | 172,852 | 165,308 | 90,869 | 94,520 |
| TOTAL | $1,751,580 | $1,894,607 | $1,885,825 | $1,810,153 | $2,123,812 |
| Total Liabilities | $2,405,239 | $2,345,350 | $2,384,479 | $2,347,037 | $2,743,416 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,855 | 93,547 | 93,279 | 93,149 | 87,982 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -4,446,213 | -4,491,868 | -4,450,931 | -4,426,991 | -3,910,236 |
| Other shareholders' equity | 918 | -638 | -1,055 | -419 | -1,664 |
| TOTAL | $859,337 | $764,357 | $741,411 | $712,749 | $384,950 |
| Total Liabilities And Equity | $3,264,576 | $3,109,707 | $3,125,890 | $3,059,786 | $3,128,366 |